INT14556

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.69
First Reported 1990
Last Reported 2010
Negated 3
Speculated 5
Reported most in Abstract
Documents 105
Total Number 111
Disease Relevance 52.21
Pain Relevance 24.04

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Igf1) extracellular region (Igf1)
Anatomy Link Frequency
Plasma 6
brain structure 5
sensory neurons 5
liver 5
muscle 5
Igf1 (Mus musculus)
Pain Link Frequency Relevance Heat
Calcitonin gene-related peptide 152 100.00 Very High Very High Very High
opiate 2 100.00 Very High Very High Very High
qutenza 140 99.98 Very High Very High Very High
narcan 10 99.98 Very High Very High Very High
tolerance 109 99.78 Very High Very High Very High
Somatostatin 357 99.76 Very High Very High Very High
Osteoarthritis 7 99.74 Very High Very High Very High
fluoxetine 19 99.72 Very High Very High Very High
Demyelination 34 99.28 Very High Very High Very High
Central nervous system 30 99.16 Very High Very High Very High
Disease Link Frequency Relevance Heat
Apoptosis 363 100.00 Very High Very High Very High
Injury 147 100.00 Very High Very High Very High
Pituitary Cancer 67 99.84 Very High Very High Very High
Impaired Glucose Tolerance 83 99.78 Very High Very High Very High
Hematological Disease 40 99.78 Very High Very High Very High
Osteoarthritis 6 99.74 Very High Very High Very High
Hypertrophy 46 99.66 Very High Very High Very High
Obesity 164 99.64 Very High Very High Very High
Targeted Disruption 268 99.62 Very High Very High Very High
Prostate Cancer 45 99.50 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
RESULTS: Subcutaneous administration of capsaicin significantly increased dermal IGF-I levels at 30 min after administration in WT mice (p < 0.01), but not in CGRP-knockout mice.
Positive_regulation (increased) of IGF-I
1) Confidence 0.69 Published 2007 Journal Growth Horm. IGF Res. Section Body Doc Link 17569567 Disease Relevance 0.16 Pain Relevance 0
A further increase in serum IGF-1 levels with gene therapy also improved motor function, consistent with the observed prevention of both muscle atrophy and peripheral motor nerve fiber demyelination.
Positive_regulation (increase) of IGF-1 in muscle associated with demyelination and muscular atrophy
2) Confidence 0.69 Published 2008 Journal Mol. Ther. Section Abstract Doc Link 18545223 Disease Relevance 1.21 Pain Relevance 0.80
We investigated whether increasing systemic IGF-1 could improve neuronal function in hyper- and hypoalgesic STZ-treated mice.
Positive_regulation (increasing) of IGF-1 in neuronal
3) Confidence 0.69 Published 2008 Journal Mol. Ther. Section Abstract Doc Link 18545223 Disease Relevance 1.06 Pain Relevance 0.73
Administration of capsaicin increased tissue levels of IGF-I and IGF-I mRNA in various organs in wild-type (WT) mice, but not in CGRP-knock-out (CGRP-/-) mice.
Positive_regulation (increased) of IGF-I associated with targeted disruption, qutenza and calcitonin gene-related peptide
4) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Abstract Doc Link 17360009 Disease Relevance 0.51 Pain Relevance 0.70
Administration of CGRP increased tissue levels of IGF-I and IGF-I mRNA in both WT and CGRP-/- mice.
Positive_regulation (increased) of IGF-I associated with calcitonin gene-related peptide
5) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Abstract Doc Link 17360009 Disease Relevance 0.58 Pain Relevance 0.78
Administration of CGRP increased tissue levels of IGF-I and IGF-I mRNA in both WT and CGRP-/- mice.
Positive_regulation (increased) of IGF-I associated with calcitonin gene-related peptide
6) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Abstract Doc Link 17360009 Disease Relevance 0.58 Pain Relevance 0.78
Administration of capsaicin increased tissue levels of IGF-I and IGF-I mRNA in various organs in wild-type (WT) mice, but not in CGRP-knock-out (CGRP-/-) mice.
Positive_regulation (increased) of IGF-I associated with targeted disruption, qutenza and calcitonin gene-related peptide
7) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Abstract Doc Link 17360009 Disease Relevance 0.51 Pain Relevance 0.69
Although administration of capsaicin enhanced increases in IGF-I levels and reduced reperfusion-induced events in WT mice, it had no effect in CGRP-/- mice.
Positive_regulation (increases) of IGF-I associated with qutenza and calcitonin gene-related peptide
8) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Abstract Doc Link 17360009 Disease Relevance 0.56 Pain Relevance 0.90
Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I, thereby reducing reperfusion-induced apoptosis in mice.
Positive_regulation (increases) of IGF-I in sensory neurons associated with qutenza and apoptosis
9) Confidence 0.69 Published 2007 Journal Neuropharmacology Section Title Doc Link 17360009 Disease Relevance 0.48 Pain Relevance 0.82
Topical application of GG increased dermal levels of IGF-I, IGF-I mRNA, and collagen in wild-type mice, but not in CGRP-knockout mice.
Neg (not) Positive_regulation (increased) of IGF-I associated with targeted disruption
10) Confidence 0.69 Published 2010 Journal Biosci. Biotechnol. Biochem. Section Abstract Doc Link 20378988 Disease Relevance 0.38 Pain Relevance 0.21
Topical application of GG increased dermal levels of IGF-I, IGF-I mRNA, and collagen in wild-type mice, but not in CGRP-knockout mice.
Neg (not) Positive_regulation (increased) of IGF-I associated with targeted disruption
11) Confidence 0.69 Published 2010 Journal Biosci. Biotechnol. Biochem. Section Abstract Doc Link 20378988 Disease Relevance 0.38 Pain Relevance 0.21
Significant increases of the hippocampal tissue levels of CGRP, IGF-I, and IGF-I messenger RNA (mRNA) were observed after capsaicin administration in WT mice (P < 0.01) but not in CGRP-/- mice.
Positive_regulation (increases) of IGF-I associated with qutenza and calcitonin gene-related peptide
12) Confidence 0.69 Published 2009 Journal Transl Res Section Abstract Doc Link 19595440 Disease Relevance 0.52 Pain Relevance 1.07
Significant increases of the hippocampal tissue levels of CGRP, IGF-I, and IGF-I messenger RNA (mRNA) were observed after capsaicin administration in WT mice (P < 0.01) but not in CGRP-/- mice.
Positive_regulation (increases) of IGF-I associated with qutenza and calcitonin gene-related peptide
13) Confidence 0.69 Published 2009 Journal Transl Res Section Abstract Doc Link 19595440 Disease Relevance 0.52 Pain Relevance 1.07
These observations suggest that topical application of capsaicin and related compounds might be useful in the treatment of detrimental morphological changes of the skin in patients with growth hormone deficiency and those in the elderly by increasing dermal IGF-I levels.
Positive_regulation (increasing) of IGF-I in skin associated with qutenza and growth hormone deficiency
14) Confidence 0.68 Published 2007 Journal Growth Horm. IGF Res. Section Abstract Doc Link 17307377 Disease Relevance 0.10 Pain Relevance 0.55
Topical application of 0.01% capsaicin significantly increased dermal IGF-I levels from 30 to 180min (p<0.01), but not at 360min, after application in mice.
Positive_regulation (increased) of IGF-I associated with qutenza
15) Confidence 0.68 Published 2007 Journal Growth Horm. IGF Res. Section Abstract Doc Link 17307377 Disease Relevance 0 Pain Relevance 0.73
In the present study, we attempted to determine whether topical application of capsaicin and related compounds increases dermal IGF-I level in mice and whether it increases facial skin elasticity in humans.
Spec (whether) Positive_regulation (increases) of IGF-I in skin associated with qutenza
16) Confidence 0.68 Published 2007 Journal Growth Horm. IGF Res. Section Abstract Doc Link 17307377 Disease Relevance 0 Pain Relevance 0.72
Topical application of 0.01% capsaicinoids (dihydrocapsaicin and nordihydrocapsaicin), 0.01% capsinoids (capsiate, dihydrocapsiate and nordihydrocapsiate), 0.01% anandamide (an endogenous agonist of VR-1), and 0.01% nonylic acid vanillylamide (a synthetic capsaicin) significantly increased dermal IGF-I levels at 30min after topical application in mice (p<0.01).
Positive_regulation (increased) of IGF-I associated with qutenza and agonist
17) Confidence 0.68 Published 2007 Journal Growth Horm. IGF Res. Section Abstract Doc Link 17307377 Disease Relevance 0 Pain Relevance 0.79
Stimulation of sensory neurons by capsaicin increases tissue levels of IGF-I and IGF-I mRNA in various organs via increased calcitonin gene-related peptide (CGRP) release in mice.
Positive_regulation (increases) of IGF-I in sensory neurons associated with qutenza and calcitonin gene-related peptide
18) Confidence 0.68 Published 2008 Journal Curr. Med. Chem. Section Abstract Doc Link 19075656 Disease Relevance 0.37 Pain Relevance 0.36
Since administration of GH or IGF-I has some deleterious effects, pharmacological stimulation of sensory neurons leading to increased tissue IGF-I levels might be a novel therapeutic strategy for various pathologic conditions.
Positive_regulation (increased) of IGF-I in sensory neurons
19) Confidence 0.68 Published 2008 Journal Curr. Med. Chem. Section Abstract Doc Link 19075656 Disease Relevance 0.61 Pain Relevance 0.45
Topical application of capsaicin increases dermal levels of IGF-I by stimulating sensory neurons in mice and increases facial skin elasticity in humans.
Positive_regulation (increases) of IGF-I in sensory neurons associated with qutenza
20) Confidence 0.68 Published 2008 Journal Curr. Med. Chem. Section Abstract Doc Link 19075656 Disease Relevance 0.75 Pain Relevance 0.55

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox